Navigation Links
Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
Date:1/21/2008

BATESVILLE, Ind., Jan. 21 /PRNewswire-FirstCall/ -- Batesville Holdings, Inc., a wholly owned subsidiary of Hillenbrand Industries, Inc. (NYSE: HB), in conjunction with Hillenbrand's plans to separate its funeral services and medical technologies businesses, today announced the appointment of Cynthia L. Lucchese as senior vice president and chief financial officer for Batesville Holdings, Inc.

Batesville Holdings, Inc., is the present Batesville Casket Company's funeral services division of Hillenbrand Industries and will be renamed Hillenbrand, Inc., after the separation. Lucchese will assume leadership for all aspects of the future public company's accounting, external reporting, tax, financial planning, budgeting, treasury and investor relations.

Lucchese has extensive public company, executive and financial management experience. She most recently served as senior vice president and chief financial officer of Thoratec Corporation. Prior to joining Thoratec, she spent more than a decade with Guidant Corporation in a variety of senior financial management roles, including vice president and treasurer, corporate controller and chief accounting officer, and vice president of finance and administration for the Guidant Sales Corporation. She also spent seven years with Eli Lilly and Company and several years with the audit division of Ernst & Young. Lucchese holds a bachelor of science degree with distinction in accounting and a master's of business administration in finance from the Indiana University Kelley School of Business.

"Cindy brings senior-level experience with leading publicly traded companies and we are delighted to have someone of her caliber join our team," said Kenneth A. Camp, president and chief executive
'/>"/>

SOURCE Hillenbrand Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
2. HearAtLast Holdings, Inc. Provides Shareholder Update
3. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
4. China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008
5. Eastern Insurance Holdings, Inc. Announces Quarterly Dividend
6. China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline
7. LifeCare Holdings, Inc. Announces Third Quarter Results
8. China Shenghuo Pharmaceutical Holdings, Inc. Announces Conference Call to Discuss Third Quarter FY 2007 Results
9. NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007
10. China Pharma Holdings, Inc. Announces Conference Call to Discuss Third Quarter 2007 Results
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...National HIV Vaccine Awareness Day, May,18, WASHI...x years into the,AIDS epidemic, someone is newly i...unday, May 18, HIV Vaccine Awareness Day, AIDS Act... Institute of Allergy and Infectious,Disease (NIAI...s everyone,to help end the AIDS epidemic by partic...
(Date:5/16/2008)...untsworth plc (LSE: HNT), "the Group",a leading i...nications,group headquartered in London, released ...Group,s performance in the first quarter 2008 (the...follows below., 15 May 2008, ...erim Management Statement, Record net ...
(Date:5/16/2008)... More in 2007, WASHINGTON, May 16 /PRNewswire-USN...cancer deaths, the National Cancer Institute (NCI)...in lung cancer research in 2007,according to upda...) today., The two other federal agencies with sig...isease Control and Prevention (CDC) and the,Depart...
(Date:5/16/2008)...Comprehensive Income increased 42% to $9.7 million... - 2007 Gross Margin of 76%, - Product Sales Back... million from $2.4 million as of December 31, 200...stCall/ -- Huiheng,Medical, Inc. ("Huiheng" or the...sed leader in the development, sales and support o...
Breaking Medicine News(10 mins):Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6
...n for cancer, anyone? Yes, Oxford University resea...can prevent bowel cancer developing . Taking a dos...tion. Long-term aspirin use is generally not back...mach problems, but the team said it could benefit ...
...a research reveals that two thirds of those who ta...delines before doing so. In other words , those us...so on the basis of blind faith and do not care to ...ms or seek evidence based results. The researcher...
...S federal receiver Robert Sillen, hired to improve...bitious turnaround plan for his jurisdiction. Ac... the unconscionable human suffering" in prison and...es from diseases carried by inmates cycling in and...
...g man working as a cleaner for a Tasmanian school ...pturing children in the bathroom on film , and mak... of Hobart pleaded guilty to three counts of indec...child exploitation material, and one count of poss...
Other Medicine News:Health News:Aspirin can Prevent Bowel Cancer, Says UK Study 2Health News:Blind Faith Dictates Use Of Herbal Supplements In Many 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 3
(Date:5/15/2008)...ch, a publishing and,information services company ...finds that investigative sites are required to lea... More than 75% of respondents to a recent,CenterWa... three or more,EDC systems. In addition, a majorit...aining had improved., State of the Clinical Trial...
(Date:5/15/2008)...Call/ -- Novavax, Inc. (Nasdaq:,NVAX) today announ...I/IIa,study of its pandemic influenza vaccine incl...able interim results from the first phase of the s... adult volunteers, were,reported in December 2007....s well tolerated and immunogenic at the 15 microgr...
(Date:5/15/2008)...tions Blue Cross Blue Shield of Michigan to W... HealthLeaders-InterStudy, NA...rs-InterStudy, the,leading provider of managed car... continues to stagnate in Michigan, Blue Cross Blu...all of its competitors to weather the,economic sto...
(Date:5/15/2008)... Genous, Boston Scientific,s ...eal-World Use of Genous, Stent,s Performance in P...l-Antiplatelet Ther...usNeich today announced,that multiple clinical dat...port the use of the company,s Genous Bio-engineere...
Breaking Medicine Technology:CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 1Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 1CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 3GrantAdler Shipping Novel Implantable Vascular Access Port 1719 1GrantAdler Shipping Novel Implantable Vascular Access Port 1719 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 1Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 3
...re-FirstCall/ --,Schering-Plough Corporation annou...ts novel oral thrombin receptor antagonist (TRA),S...entific Sessions,of the of Cardiology (ACC.07)/Inn...n New Orleans. The Phase II trial, referred to,as ...oronary,Intervention (TRA-PCI) trial, has been acc...
...an TNFa, LAUSANNE, Switzerland, March 12, 2007 /PR...al independent biopharmaceutical,development compa...nditions, announces the presentation of preclinica... Debio-0512 as an anti-TNFa,therapeutic vaccine, t...ls of acute and chronic inflammation. Debio-0512 i...
Other Medicine Technology:Schering-Plough Announces Presentation of Phase II Trial Results,for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual,Meeting of The American College of Cardiology/i2 Summit 2Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2
...ystem treats female urinary stress incontinence (S...er a suprapubic (BioArcTM SP) or a transobturator ...e hybrid system combining synthetic and biologic m...ailable. The BioArc utilizes a polypropylene mesh ...
...ing System utilizes a suprapubic approach to treat...l hypermobility and/or intrinsic sphincter deficie... needles and a self-fixating sling with a resorbab...ve tension refinement without mesh distortion, as ...
...Ultra Sling is a minimally invasive treatment for ...repair surgery can be performed at the same time. ...e a sling, the In-Fast Ultra inserter is used to d...rior aspect of the pubic bone. Each screw has a su...
Proven tension-free sling technology marries with the well-researched Pelvicol® porcine acellular collagen matrix sling, for exceptional resultsby design. Natural tissue-to-tissue contact between
Medicine Products: